These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 10507939)
1. Corticosteroid treatment of asthma: now at the crossroads. Reply to Drs Seale and Donnelly. Szefler SJ Respir Med; 1999 Feb; 93(2):142-4. PubMed ID: 10507939 [No Abstract] [Full Text] [Related]
2. Corticosteroid treatment of asthma: now at the crossroads. Reply to Drs Seale and Donnelly. Bisgaard H Respir Med; 1999 Feb; 93(2):144-5. PubMed ID: 10507940 [No Abstract] [Full Text] [Related]
3. Corticosteroid treatment of asthma: now at the crossroads. Reply to Drs Seale and Donnelly. Jolobe OM Respir Med; 1999 Feb; 93(2):145-6. PubMed ID: 10507942 [No Abstract] [Full Text] [Related]
4. Corticosteroid treatment of asthma: now at the crossroads. Reply to Drs Seale and Donnelly. Dluhy RG Respir Med; 1999 Feb; 93(2):145. PubMed ID: 10507941 [No Abstract] [Full Text] [Related]
5. [Clinical study on bronchial asthma and leukotriene antagonists]. Yokoyama A Nihon Naika Gakkai Zasshi; 2004 Dec; 93(12):2656-61. PubMed ID: 15658499 [No Abstract] [Full Text] [Related]
6. Leukotriene receptor antagonists as add-on therapy for adults with asthma. Thomson NC; Shepherd M Thorax; 2003 Mar; 58(3):190-2. PubMed ID: 12612289 [TBL] [Abstract][Full Text] [Related]
7. Which patients with asthma could benefit from using anti-leukotriene drugs: an evidence based review. Joos GF Pol Arch Med Wewn; 2008 Dec; 118(12):689-90. PubMed ID: 19202944 [No Abstract] [Full Text] [Related]
8. Weighing the risks of treatment versus nontreatment in pediatric asthma. Spahn JD; Covar RA Pediatr Clin North Am; 2003 Jun; 50(3):677-95. PubMed ID: 12877241 [TBL] [Abstract][Full Text] [Related]
9. Disagreement between guidelines regarding the third step of asthma drug therapy for school-age children. Miceli Sopo S; Bersani G; Del Vescovo E; Gelsomino M Allergol Immunopathol (Madr); 2020; 48(6):789-791. PubMed ID: 32371029 [TBL] [Abstract][Full Text] [Related]
10. When an asthma drug has an inferiority complex: a noninferiority trial. Goodman DC Pediatrics; 2005 Aug; 116(2):493-5. PubMed ID: 16061609 [No Abstract] [Full Text] [Related]
11. Treatment of bullous pemphigoid with a leukotriene receptor antagonist. Nomura A; Fujisawa H; Sekizawa K Allergy; 2003 Feb; 58(2):162-3. PubMed ID: 12622754 [No Abstract] [Full Text] [Related]
12. Study design is a major determinant of whether equivalence or superiority is demonstrated. Stoloff SW; Stempel DA J Allergy Clin Immunol; 2003 Jun; 111(6):1413; author reply 1413-4. PubMed ID: 12789251 [No Abstract] [Full Text] [Related]
13. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? Yes. Drazen JM; Israel E Am J Respir Crit Care Med; 1998 Dec; 158(6):1697-8. PubMed ID: 9847254 [No Abstract] [Full Text] [Related]
14. Should antileukotriene therapies be used instead of inhaled corticosteroids in asthma? No. Wenzel SE Am J Respir Crit Care Med; 1998 Dec; 158(6):1699-701. PubMed ID: 9847255 [No Abstract] [Full Text] [Related]
15. Leukotriene antagonists offer a new mechanism for asthma control. Capriotti T Medsurg Nurs; 1999 Oct; 8(5):318-22. PubMed ID: 10661171 [No Abstract] [Full Text] [Related]